These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 32295420)

  • 41. Cardiovascular pharmacology of nonselective nonsteroidal anti-inflammatory drugs and coxibs: clinical considerations.
    FitzGerald GA
    Am J Cardiol; 2002 Mar; 89(6A):26D-32D. PubMed ID: 11909558
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Nonsteroidal anti-inflammatory drugs and heart failure.
    Bleumink GS; Feenstra J; Sturkenboom MC; Stricker BH
    Drugs; 2003; 63(6):525-34. PubMed ID: 12656651
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Nonsteroidal anti-inflammatory drugs and cardiovascular safety - translating pharmacological data into clinical readouts.
    Tacconelli S; Bruno A; Grande R; Ballerini P; Patrignani P
    Expert Opin Drug Saf; 2017 Jul; 16(7):791-807. PubMed ID: 28569569
    [TBL] [Abstract][Full Text] [Related]  

  • 44. COX isoforms in the cardiovascular system: understanding the activities of non-steroidal anti-inflammatory drugs.
    Mitchell JA; Warner TD
    Nat Rev Drug Discov; 2006 Jan; 5(1):75-86. PubMed ID: 16485347
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Gastrointestinal effects of nonsteroidal anti-inflammatory drugs.
    Whittle BJ
    Fundam Clin Pharmacol; 2003 Jun; 17(3):301-13. PubMed ID: 12803569
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Cyclo-Oxygenase (COX) Inhibitors and Cardiovascular Risk: Are Non-Steroidal Anti-Inflammatory Drugs Really Anti-Inflammatory?
    Khan S; Andrews KL; Chin-Dusting JPF
    Int J Mol Sci; 2019 Aug; 20(17):. PubMed ID: 31480335
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Prostanoids in nociception and pain.
    Zeilhofer HU
    Biochem Pharmacol; 2007 Jan; 73(2):165-74. PubMed ID: 16959219
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Microsomal prostaglandin E
    Zhang YY; Yao YD; Luo JF; Liu ZQ; Huang YM; Wu FC; Sun QH; Liu JX; Zhou H
    Pharmacol Res; 2022 Jan; 175():105977. PubMed ID: 34798265
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effects of cyclooxygenase inhibition on the gastrointestinal tract.
    Radi ZA; Khan NK
    Exp Toxicol Pathol; 2006 Nov; 58(2-3):163-73. PubMed ID: 16859903
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Cardiovascular complications of non-steroidal anti-inflammatory drugs.
    Fosslien E
    Ann Clin Lab Sci; 2005; 35(4):347-85. PubMed ID: 16254252
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Molecular basis for the inhibition of prostanoid biosynthesis by nonsteroidal anti-inflammatory agents.
    Smith WL; DeWitt DL; Shimokawa T; Kraemer SA; Meade EA
    Stroke; 1990 Dec; 21(12 Suppl):IV24-8. PubMed ID: 2175460
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Role of cyclooxygenase-2 in the generation of vasoactive prostanoids in the rat pulmonary and systemic vascular beds.
    Baber SR; Champion HC; Bivalacqua TJ; Hyman AL; Kadowitz PJ
    Circulation; 2003 Aug; 108(7):896-901. PubMed ID: 12900348
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Cyclo-oxygenase-2 contributes to constitutive prostanoid production in rat kidney and brain.
    Hétu PO; Riendeau D
    Biochem J; 2005 Nov; 391(Pt 3):561-6. PubMed ID: 16008526
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Cardiovascular biology of microsomal prostaglandin E synthase-1.
    Wang M; FitzGerald GA
    Trends Cardiovasc Med; 2010 Aug; 20(6):189-95. PubMed ID: 22137640
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Recent development of selective cyclooxygenase-2 inhibitors].
    Kawai S
    Nihon Rinsho; 2002 Dec; 60(12):2370-7. PubMed ID: 12510364
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Prostanoid function and cardiovascular disease.
    Iñiguez MA; Cacheiro-Llaguno C; Cuesta N; Díaz-Muñoz MD; Fresno M
    Arch Physiol Biochem; 2008 Jul; 114(3):201-9. PubMed ID: 18629685
    [TBL] [Abstract][Full Text] [Related]  

  • 57. New insights into COX-2 biology and inhibition.
    Patrignani P; Tacconelli S; Sciulli MG; Capone ML
    Brain Res Brain Res Rev; 2005 Apr; 48(2):352-9. PubMed ID: 15850674
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Microsomal Prostaglandin E Synthase-1-Derived PGE2 Inhibits Vascular Smooth Muscle Cell Calcification.
    Gao C; Fu Y; Li Y; Zhang X; Zhang L; Yu F; Xu SS; Xu Q; Zhu Y; Guan Y; Wang X; Kong W
    Arterioscler Thromb Vasc Biol; 2016 Jan; 36(1):108-21. PubMed ID: 26543101
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Gastrointestinal safety of selective COX-2 inhibitors.
    Hawkey CJ; Skelly MM
    Curr Pharm Des; 2002; 8(12):1077-89. PubMed ID: 11945152
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The future of traditional nonsteroidal antiinflammatory drugs and cyclooxygenase-2 inhibitors in the treatment of inflammation and pain.
    Sciulli MG; Capone ML; Tacconelli S; Patrignani P
    Pharmacol Rep; 2005; 57 Suppl():66-85. PubMed ID: 16415488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 12.